About: Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1987

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1987 (uk) article scientifique publié en 1987 (fr) im Juli 1987 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1987 (ast) scientific article published on 01 July 1987 (en)
publication date	wds:Q69901572-F579F552-D664-46D2-B7AB-02FC7F2D7CA8
publication date	1987-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69901572-D161323A-D76E-40F8-9A62-9F52E49A7F90
language of work or name	English
cites work	wds:Q69901572-0C9F85B7-8FB2-4DBE-A0C2-7CB444B9AF09 wds:Q69901572-10AF7909-44A7-4D80-B1BE-1E04E97953A9 wds:Q69901572-1199C1F8-93AB-4C00-ACC8-BE2BD59AC5A3 wds:Q69901572-1CB0B953-E45F-4E46-97E0-F31C30BE6818 wds:Q69901572-20D7C4B7-9323-41DC-883C-E9BB1C196E36 wds:Q69901572-25DFA79B-2439-4C65-A295-0DA68F3E1F44 wds:Q69901572-2B4A38BF-CC5D-4E88-A8E9-B745F686AB20 wds:Q69901572-3C978F2B-9D9C-4FDA-BB22-63CB055AA001 wds:Q69901572-3F765F2C-60D5-40BE-A907-0F58EC5ED572 wds:Q69901572-43CAFEF1-3591-4BFF-A98D-C4AB0B79CB14 wds:Q69901572-456A0077-F37E-4C6C-8C1B-FB383CF396DD wds:Q69901572-4745ED00-67EA-43C7-BC1F-36525CBB7EBC wds:Q69901572-56B8FC83-1C83-4748-A32C-6F39A56EB2C3 wds:Q69901572-616885D3-A3B3-47BD-8CD6-0CF6CFB97E33 wds:Q69901572-61C3384A-8C49-4343-9CAB-3ECEE6F10316 wds:Q69901572-65387387-683D-4DEC-8191-8F2261ED9817 wds:Q69901572-65FB5F23-3257-4AEB-B44C-A99FC02E5F7B wds:Q69901572-666CCA59-8EA0-4398-B573-59FD2001D416 wds:Q69901572-671CC3A9-8DA5-457C-A3D4-E9AE7CB9C380 wds:Q69901572-69F1EB8D-6510-48CC-B7BE-A1B6A5071864 wds:Q69901572-706B9AD0-0F84-4665-AD22-0A9BAC054B61 wds:Q69901572-75B62B95-1033-4724-A81C-8632F41A672E wds:Q69901572-806FCA49-4B81-4B1E-BBA1-292EB00A464A wds:Q69901572-81CB9620-6363-4925-93B9-9779B7A22043 wds:Q69901572-97F1A618-3D7A-427C-BAD6-C2E8D142F95D wds:Q69901572-ACF7230B-872A-4C0C-A082-D54E173A989F wds:Q69901572-B533BFE0-1194-4A1C-A2CB-E8CDD72B085D wds:Q69901572-D41BD9EB-A03E-4632-A49C-23DCD765158C wds:Q69901572-D88C5185-AF6B-463B-AA92-B93641E5F277 wds:Q69901572-DA5C6405-7DC0-48AD-A915-0BD9124AA5B7 wds:Q69901572-DBEC421C-52C9-419A-9BC9-48BD0D230368 wds:Q69901572-E0AB980D-9A1E-4596-A0EB-D623AAC70623 wds:Q69901572-EEDA6E8D-AC48-4EC6-A322-0DBDACEAA1B8 wds:Q69901572-FB77E0A1-DACD-4C64-A378-B9E6ADBCBFBF
cites work	Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus Intravenous streptokinase in evolving acute myocardial infarction Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature Immunochemical quantitation of antigens by single radial immunodiffusion Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Lipoprotein fractionation Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study On the intravenous glucose tolerance test. The use of biplane angiocardigraphy for the measurement of left ventricular volume in man Haemostatic function in myocardial infarction Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). Studies of F VIII procoagulant activity in plasma and concentrates using a semi-automated thrombin generation assay Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma Fibrinogen as a risk factor for stroke and myocardial infarction Insulin release, insulin sensitivity, and glucose intolerance Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies Use of radionuclide angiography and an electrocardiographic stress test to diagnose multivessel disease after a first episode of uncomplicated myocardial infarction Prognostic value of exercise testing, coronary angiography and left ventriculography 6--8 weeks after myocardial infarction Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction Nonsurgical reperfusion in evolving myocardial infarction Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction Is there an indication for coronary angiography in patients under 60 years of age with no or minimal angina pectoris after a first myocardial infarction?
author name string	wds:Q69901572-14C94784-44AE-4B82-B1A5-E79C797C74A0 wds:Q69901572-707BE122-092E-4031-B5CB-8AAE5D3CD09A wds:Q69901572-782808ED-903B-40AD-A03F-4407741E5E47 wds:Q69901572-81639C06-FC72-42B6-ACD7-0ABA80F6E3E8 wds:Q69901572-DCDEADAE-CA51-43BB-B466-E389C2FA5FCD wds:Q69901572-E639B63C-30D4-4BA2-88B6-569B6984B70A
author name string	M Blombäck B Wiman G Walldius G Dahlén C Landou A Szamosi
rdfs:label	Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction (en) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction (nl)
skos:prefLabel	Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction (en) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction (nl)
name	Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction (en) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction (nl)
author	wds:Q69901572-4ADCD38B-A426-41E4-9AC2-892A6C733CE6 wds:Q69901572-B0CEF80E-29C5-45A5-9D74-88889D764AC6
author	Ulf de Faire

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software